Alaska 2023-2024 Regular Session

Alaska House Bill HCR9

Introduced
2/15/24  
Introduced
2/15/24  
Report Pass
3/22/24  
Refer
2/15/24  
Report Pass
3/22/24  

Caption

Mental Health/substance Assistance Parity

Impact

The resolution identifies critical shortcomings in the state’s medical assistance plan, which currently operates as a fee-for-service model not mandated to comply with the parity requirements of the MHPAEA. It emphasizes the need for comprehensive regulations that would streamline accessibility to mental health care, remedying the ongoing administrative challenges that create barriers to effective treatment. By urging the Department of Health to revise its current framework, HCR9 aims to align state laws with established federal standards, ultimately promoting a more integrated approach to health care that includes both physical and behavioral health.

Summary

HCR9 is a House Concurrent Resolution introduced in the Alaska State Legislature addressing the pressing need for equity in mental health and substance use disorder medical assistance benefits. The resolution advocates for the adoption of regulations that ensure parity between mental health services and traditional medical care, reflecting the overarching goals set forth by the federal Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008. The resolution underscores the disparities currently faced by mental health providers and their clients, including an overly complex regulatory environment that significantly hinders access to necessary treatment services.

Contention

There is a potential point of contention surrounding HCR9, as it addresses the discrepancies in regulations that favor traditional medical treatments over mental health care provisions. Critics may argue about the implications of increasing the regulatory burden on the Department of Health and possible pushback from providers of other medical services affected by the changes. The conversation about ensuring equitable treatment access will likely invoke broader discussions about resource allocation and government involvement in healthcare, raising concerns about balancing regulatory oversight with the autonomy of healthcare providers.

Companion Bills

No companion bills found.

Previously Filed As

AK S3109

Requires DOBI to monitor, evaluate, and submit annual report concerning mental health parity.

AK HB1432

AN ACT Relating to improving access to appropriate mental health and substance use disorder services by updating Washington's mental health parity law and ensuring coverage of medically necessary care;

AK SB5477

Improving access to appropriate mental health and substance use disorder services.

AK SB45

Medicaid Mental Health Parity

AK HB06145

An Act Concerning Mental Health And Substance Use Parity, Compliance And Transparency.

AK HB1141

Mental health and substance abuse coverage.

AK HB1085

INS CD-MENTAL HEALTH PARITY

AK SB0055

INS CD-MENTAL HEALTH PARITY

AK H7946

Requires health insurers to comply with federal mental health parity laws, prevent discriminatory treatment limits, and ensures meaningful mental health and substance use coverage in all benefit classifications.

AK S2687

Requires health insurers to comply with federal mental health parity laws, prevent discriminatory treatment limits, and ensures meaningful mental health and substance use coverage in all benefit classifications.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.